2016 Pancreatic Cancer Conference

Key Topics

• Novel agents in clinical care and clinical trial participation
• Patients who will benefit from radiation therapy
• Molecular biology of pancreatic cancer
• Palliative care management of the symptomatic patient
• The appropriate regimen for first and second line therapy in treating advanced pancreatic cancer
• The role of the PARP inhibitors and DNA damaging agents in the treatment of pancreatic cancer
• Patients with resecetable pancreatic cancer who are candidates for a minimally invasive procedure
• The differences in staging between borderline and unresectable locally advanced pancreatic cancer
• The role of proton therapy and potential uses in pancreatic cancer

Who should Attend

• Gastroenterologists
• Surgeons
• Medical oncologists
• Radiation oncologists
• NPs
• Pain specialists
• RNs
• PAs